RESUMEN
Drug-induced secondary angle closure is quite common and in the majority of cases simply stopping the medication leads to rapid reversal of the condition and resolution of glaucoma. We describe here a patient who presented with secondary angle closure glaucoma and myopia following mefenamic acid ingestion which was managed successfully by stopping the medication, symptomatic treatment and reassurance.
Asunto(s)
Adulto , Antiinflamatorios no Esteroideos/efectos adversos , Antiinflamatorios no Esteroideos/uso terapéutico , Coroides/diagnóstico por imagen , Enfermedades de la Coroides/inducido químicamente , Enfermedades de la Coroides/diagnóstico , Diagnóstico Diferencial , Glaucoma de Ángulo Cerrado/inducido químicamente , Glaucoma de Ángulo Cerrado/diagnóstico , Gonioscopía , Cefalea/tratamiento farmacológico , Humanos , Presión Intraocular , Masculino , Ácido Mefenámico/efectos adversos , Ácido Mefenámico/uso terapéutico , Miopía/inducido químicamente , Miopía/diagnóstico , Refracción OcularRESUMEN
OBJECTIVE: To report three cases of delayed choroidal detachment after treatment with topical prostaglandin analogs. MATERIAL AND METHOD: Intervention three case reports. Four eyes of three patients with chronic angle closure glaucoma developed choroidal detachment after using topical prostaglandin analogs. RESULTS: Three patients with chronic angle closure glaucoma developed chroidal detachment in one week, three weeks and two years after using travoprost, bimatoprost and latanoprost respectively. All of them resolved after discontinuation of these medications. All of the eyes that developed chroidal detachment were pseudophakic. CONCLUSION: Travoprost, bimatoprost and latanoprost may lead to choroidal detachment and hypotony. Pseudophakic patients may be at high risk of the development of chroidal detachment. Topical prostaglandin analogs should be used cautiously in these patients.
Asunto(s)
Administración Tópica , Anciano , Amidas , Enfermedades de la Coroides/inducido químicamente , Cloprostenol/efectos adversos , Femenino , Glaucoma de Ángulo Cerrado/tratamiento farmacológico , Humanos , Lípidos/efectos adversos , Persona de Mediana Edad , Hipotensión Ocular , Prostaglandinas F Sintéticas/efectos adversos , Prostaglandinas Sintéticas/efectos adversos , Factores de Riesgo , Factores de TiempoRESUMEN
There is increasing evidence in the literature implicating the use of exogenous steroids through various routes as a risk factor for the development of idiopathic central serous chorioretinopathy (ICSC). We report a case of acute bilateral ICSC following intra-articular injection of corticosteroids.
Asunto(s)
Enfermedad Aguda , Adulto , Sangre , Enfermedades de la Coroides/inducido químicamente , Femenino , Angiografía con Fluoresceína , Glucocorticoides/efectos adversos , Humanos , Inyecciones Intraarticulares , Enfermedades de la Retina/inducido químicamente , Tenosinovitis/tratamiento farmacológico , Triamcinolona Acetonida/efectos adversos , Articulación de la Muñeca/efectos de los fármacosRESUMEN
Tamoxifen is an antioestrogen drug used widely in the management of oestrogen-dependent metastatic breast carcinoma. A number of ocular complications have been described secondary to tamoxifen therapy. We report two patients, one of whom had superior ophthalmic vein thrombosis and the other who had painful proptosis and acute angle-closure glaucoma with choroidal detachment secondary to tamoxifen therapy, both of which have not been reported earlier. In both patients the signs and symptoms resolved rapidly after the discontinuation of tamoxifen therapy. Awareness of the ocular toxicity of tamoxifen is essential as prompt withdrawal can result in resolution of most of the complications.